News archive.
Earlier AI news and analysis, kept for reference. Current coverage lives in News & Analysis.
Pfizer's Hympavzi Now Covers Kids 6+ With Haemophilia A or B
FDA expanded Hympavzi approval to children aged 6–11 and adolescents 12+ with inhibitors. The once-weekly injection showed 93% bleeding reduction versus on-demand IV treatment in Phase III trials.
J&J buys Firefly Bio for $1B to target KRAS cancers
Johnson & Johnson is acquiring Firefly Bio for $1 billion to add its Firelink degrader-antibody conjugate platform to its oncology pipeline. The deal targets KRAS-driven solid tumors, where treatment options remain limited.
Spain's pharma sector pulls €1.5B in annual R&D as multinationals expand
Spain ranks third in EU scientific output and leads Europe in clinical trials approved annually. Merck, Eli Lilly, Bayer, and a dozen other pharma giants are investing billions. Here's why the country is becoming a magnet for life science capital.
CRISPR Targets p53 Mutations in Half of All Cancers
Jennifer Doudna's lab engineered a CRISPR system that kills cancer cells by recognizing mutant p53 mRNA with single-nucleotide precision. Mouse studies show the approach works on lung and liver tumors.
Lawyers Can Now Catch AI-Invented Case Citations Before Filing
BrentWorks launched CiteSentinel to scan legal briefs for fabricated cases, statutes, and authorities before they reach a judge. The tool works on your own drafts, co-counsel submissions, and opposing filings.
Institut Pasteur Funds $17M Chikungunya Vaccine Trial Across Africa
EU-backed ACT-CHIK project will test MV-CHIK vaccine in Rwanda, Kenya, Nigeria, and Senegal while preparing local manufacturing. Here's what the trial covers and why African vaccine sovereignty matters.
AI designs caffeine-triggered kill switch for CAR T cells
Texas A&M researchers used protein design to turn caffeine into a molecular off-switch for engineered cells. The system could let doctors pause cell therapies without destroying them.
95% of Detectable HIV in Treated Patients Is Defective RNA
Johns Hopkins researchers found that nearly all persistent viral traces in people on long-term HIV therapy are non-infectious copies. A new diagnostic tool could spare patients unnecessary drug changes and anxiety.
Antibiotic resistance genes found across all world oceans
Italian-led SeA Care project detected resistance genes in over 140 ocean sites across five basins, with highest concentrations near shipping routes and coastal cities. Study suggests oceans function as a global reservoir for land-based pollution.
India completes nationwide rollout of Ayushman Bharat health scheme with West Bengal
West Bengal became the 36th state to join PM-JAY on June 9, completing universal coverage. The scheme has funded 12 crore treatments worth Rs 1.82 lakh crore since 2018.
Air pollution damages placenta, cuts fetal growth in AIIMS study
AIIMS Delhi found PM2.5 and PM10 particles cross the placental barrier, triggering inflammation that restricts fetal development and increases low birth weight risk. The study identified toxic metals and a suppressed growth gene.
Haleon invests ₹2,000 crore in first Indian manufacturing plant
Haleon is building a 40-acre automated facility in Madhya Pradesh expected to open by 2029–30, creating 500 direct jobs. Why the maker of Sensodyne is betting on India now.